In January 2022, the Scientific Advisory Council of the International Alliance of ALS/MND Associations released four updated briefing notes, to provide information on advances and issues related to MND research. The updated briefing notes pertain to:

• Amylyx - AMX0035
• Mitsubishi Tenabe Pharma America – Oral Edaravone
• Brainstorm Cell Therapeutics – NurOwn
• Clene Nanomedicine – CNM-Au8

You can read the briefing notes in full by visiting the MND Australia SAC update page.